{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:40:40Z","timestamp":1770457240300,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004233","name":"Universitat Polit\u00e8cnica de Val\u00e8ncia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Government of the Basque Country","doi-asserted-by":"publisher","award":["IT907-16"],"award-info":[{"award-number":["IT907-16"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003451","name":"University of the Basque Country","doi-asserted-by":"publisher","award":["ESPDOC19\/47"],"award-info":[{"award-number":["ESPDOC19\/47"]}],"id":[{"id":"10.13039\/501100003451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003451","name":"University of the Basque Country","doi-asserted-by":"publisher","award":["PIF17\/79"],"award-info":[{"award-number":["PIF17\/79"]}],"id":[{"id":"10.13039\/501100003451","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejpb.2021.09.011","type":"journal-article","created":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T05:51:46Z","timestamp":1633153906000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Sphingolipid extracts enhance gene delivery of cationic lipid vesicles into retina and brain"],"prefix":"10.1016","volume":"169","author":[{"given":"Nuseibah","family":"AL Qtaish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idoia","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilia","family":"Villate- Beitia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Sainz-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Mart\u00ednez-Navarrete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Soto-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"G\u00e1lvez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania B.","family":"Lopez-Mendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Puras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Luis Pedraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6372","key":"10.1016\/j.ejpb.2021.09.011_b0005","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4672","article-title":"Gene Therapy Comes of Age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ejpb.2021.09.011_b0010","doi-asserted-by":"crossref","DOI":"10.1038\/d41573-019-00154-0","article-title":"Gene Therapy Boom Continues","volume":"18","author":"Mullard","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejpb.2021.09.011_b0015","doi-asserted-by":"crossref","DOI":"10.1186\/s40824-019-0156-z","article-title":"Recent Advances in the Development of Gene Delivery Systems","volume":"23","author":"Sung","year":"2019","journal-title":"Biomater. Res."},{"key":"10.1016\/j.ejpb.2021.09.011_b0020","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3389\/fphar.2019.00724","article-title":"Gene Therapy Tools for Brain Diseases","volume":"10","author":"Ingusci","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2021.09.011_b0025","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nri1224","article-title":"Ocular Immune Privilege: Therapeutic Opportunities from an Experiment of Nature","volume":"3","author":"Streilein","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejpb.2021.09.011_b0030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/156652306779010688","article-title":"Intracellular Trafficking of Plasmids for Gene Therapy: Mechanisms of Cytoplasmic Movement and Nuclear Import","volume":"6","author":"Vaughan","year":"2006","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ejpb.2021.09.011_b0035","doi-asserted-by":"crossref","DOI":"10.4103\/2277-9175.98152","article-title":"Viral and Nonviral Delivery Systems for Gene Delivery","volume":"1","author":"Nayerossadat","year":"2012","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.ejpb.2021.09.011_b0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2015.12.012","article-title":"Non-Viral Gene Therapy: Gains and Challenges of Non-Invasive Administration Methods","volume":"240","author":"Foldvari","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.09.011_b0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cis.2017.12.006","article-title":"A Review on Cationic Lipids with Different Linkers for Gene Delivery","volume":"253","author":"Zhi","year":"2018","journal-title":"Adv. Colloid Interface Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2021.09.011_b0050","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1039\/C4OB02087A","article-title":"Niosomes based on synthetic cationic lipids for gene delivery: the influence of polar head-groups on the transfection efficiency in HEK-293, ARPE-19 and MSC-D1 cells","volume":"13","author":"Ojeda","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"5","key":"10.1016\/j.ejpb.2021.09.011_b0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/nano7050094","article-title":"Recent Advances in Nanomaterials for Gene Delivery-A Review","volume":"7","author":"Riley","year":"2017","journal-title":"Nanomaterials (Basel)"},{"issue":"174","key":"10.1016\/j.ejpb.2021.09.011_b0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2013.11.004","article-title":"A novel cationic niosome formulation for gene delivery to the retina","volume":"28","author":"Puras","year":"2014","journal-title":"J. Control Release."},{"issue":"2","key":"10.1016\/j.ejpb.2021.09.011_b0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/pharmaceutics11020050","article-title":"Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and Opportunities in Gene Delivery","volume":"11","author":"Grijalvo","year":"2019","journal-title":"Pharmaceutics."},{"issue":"4","key":"10.1016\/j.ejpb.2021.09.011_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194179","article-title":"Niosomes, an Alternative for Liposomal Delivery","volume":"13","author":"Bartelds","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2021.09.011_b0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijpharm.2016.02.043","article-title":"The Role of Helper Lipids in the Intracellular Disposition and Transfection Efficiency of Niosome Formulations for Gene Delivery to Retinal Pigment Epithelial Cells","volume":"503","author":"Ojeda","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.09.011_b0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.biomaterials.2015.11.017","article-title":"The influence of the polar head-group of synthetic cationic lipids on the transfection efficiency mediated by niosomes in rat retina and brain","volume":"77","author":"Ojeda","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2021.09.011_b0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2017.03.386","article-title":"Retinal Gene Delivery Enhancement by Lycopene Incorporation into Cationic Niosomes Based on DOTMA and Polysorbate 60","volume":"254","author":"Mashal","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.09.011_b0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2019.05.010","article-title":"Gene Delivery to the Rat Retina by Non-Viral Vectors Based on Chloroquine-Containing Cationic Niosomes","volume":"304","author":"Mashal","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.09.011_b0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","article-title":"Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis","volume":"33","author":"Chun","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ejpb.2021.09.011_b0100","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-019-1497-6","article-title":"Role of Ceramides in Drug Delivery","volume":"20","author":"Alrbyawi","year":"2019","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.ejpb.2021.09.011_b0105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tvjl.2016.03.020","article-title":"Effects of sphingolipid extracts on the morphological structure and lipid profile in an in vitro model of canine skin","volume":"212","author":"Cerrato","year":"2016","journal-title":"Vet. J."},{"issue":"2","key":"10.1016\/j.ejpb.2021.09.011_b0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF02534430","article-title":"Distribution of glycosphingolipids and ceramide of rat small intestinal mucosa","volume":"21","author":"Dahiya","year":"1986","journal-title":"Lipids"},{"key":"10.1016\/j.ejpb.2021.09.011_b0115","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejpb.2018.02.037","article-title":"Delivery of Oat-Derived Phytoceramides into the Stratum Corneum of the Skin using Nanocarriers: Formulation, Characterization and in Vitro and Ex-Vivo Penetration Studies","volume":"127","author":"Tessema","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.09.011_b0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejpb.2004.11.009","article-title":"Design of a Phytosphingosine-Containing, Positively-Charged Nanoemulsion as a Colloidal Carrier System for Dermal Application of Ceramides","volume":"60","author":"Yilmaz","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ejpb.2021.09.011_b0125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbrc.2013.04.093","article-title":"Preparation of Quercetin and Rutin-Loaded Ceramide Liposomes and Drug-Releasing Effect in Liposome-in-Hydrogel Complex system","volume":"435","author":"Park","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejpb.2021.09.011_b0130","doi-asserted-by":"crossref","first-page":"119757","DOI":"10.1016\/j.ijpharm.2020.119757","article-title":"Non-viral mediated gene therapy in human cystic fibrosis airway epithelial cells recovers chloride channel functionality","volume":"588","author":"Sainz-Ramos","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1-2","key":"10.1016\/j.ejpb.2021.09.011_b0135","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijpharm.2018.07.035","article-title":"Polysorbate 20 non-ionic surfactant enhances retinal gene delivery efficiency of cationic niosomes after intravitreal and subretinal administration","volume":"550","author":"Villate-Beitia","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.ejpb.2021.09.011_b0140","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1021\/acs.molpharmaceut.5b00496","article-title":"New Insights into Gene Delivery to Human Neuronal Precursor NT2 Cells: A Comparative Study between Lipoplexes, Nioplexes, and Polyplexes","volume":"12","author":"Agirre","year":"2015","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2021.09.011_b0145","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/acs.molpharmaceut.9b01213","article-title":"Brain Angiogenesis Induced by Nonviral Gene Therapy with Potential Therapeutic Benefits for Central Nervous System Diseases","volume":"17","author":"Gallego","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.09.011_b0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.nano.2018.12.018","article-title":"Non-viral vectors based on cationic niosomes and minicircle DNA technology enhance gene delivery efficiency for biomedical applications in retinal disorders","volume":"17","author":"Gallego","year":"2019","journal-title":"Nanomedicine."},{"issue":"4","key":"10.1016\/j.ejpb.2021.09.011_b0155","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.nano.2015.01.012","article-title":"Enduring high-efficiency in vivo transfection of neurons with non-viral magnetoparticles in the rat visual cortex for optogenetic applications","volume":"11","author":"Soto-S\u00e1nchez","year":"2015","journal-title":"Nanomedicine."},{"key":"10.1016\/j.ejpb.2021.09.011_b0160","series-title":"Biological Applications of Nanoparticles in Optical Microscopy Polymeric Nanomaterials in Nanotherapeutics","first-page":"469","author":"Margineanu","year":"2019"},{"issue":"2","key":"10.1016\/j.ejpb.2021.09.011_b0165","first-page":"81","article-title":"A Review on Phospholipids and their Main Applications in Drug Delivery Systems","volume":"10","author":"Li","year":"2015","journal-title":"Asian J. Pharmceutical Sci."},{"key":"10.1016\/j.ejpb.2021.09.011_b0170","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1194\/jlr.R800080-JLR200","article-title":"Bioactive sphingolipids: metabolism and function","volume":"50","author":"Bartke","year":"2009","journal-title":"J. Lipid. Res."},{"issue":"12","key":"10.1016\/j.ejpb.2021.09.011_b0175","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.bbamem.2006.09.011","article-title":"Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. Biochimica et Biophysica Acta (BBA) -","volume":"1758","author":"Go\u00f1i","year":"2006","journal-title":"Biomembranes"},{"key":"10.1016\/j.ejpb.2021.09.011_b0180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijpharm.2017.02.016","article-title":"Non-viral vectors based on magnetoplexes, lipoplexes and polyplexes for VEGF gene delivery into central nervous system cells","volume":"521","author":"Villate-Beitia","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.ejpb.2021.09.011_b0185","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","article-title":"Solid lipid nanoparticles for parenteral drug delivery","volume":"56","author":"Wissing","year":"2004","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"4","key":"10.1016\/j.ejpb.2021.09.011_b0190","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/pharmaceutics12040371","article-title":"Endocytosis: The Nanoparticle and Submicron Nanocompounds Gateway into the Cell","volume":"12","author":"Manzanares","year":"2020","journal-title":"Pharmaceutics."},{"issue":"3","key":"10.1016\/j.ejpb.2021.09.011_b0195","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejpb.2011.06.005","article-title":"Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway","volume":"79","author":"Delgado","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.ejpb.2021.09.011_b0200","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1582-4934.2007.00062.x","article-title":"searching for an endocytic identity and role in the uptake of cell penetrating peptides","volume":"11","author":"Jones","year":"2007","journal-title":"J. Cell. Mol. Med."},{"issue":"8","key":"10.1016\/j.ejpb.2021.09.011_b0205","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/icb.2011.20","article-title":"Macropinocytosis: an endocytic pathway for internalising large gulps","volume":"89","author":"Lim","year":"2011","journal-title":"Immunol. Cell. Biol."},{"key":"10.1016\/j.ejpb.2021.09.011_b0210","doi-asserted-by":"crossref","unstructured":"Liang, W. and Jenny K W Lam. \u201cEndosomal Escape Pathways for Non-Viral Nucleic Acid Delivery Systems.\u201d, 2012.","DOI":"10.5772\/46006"},{"issue":"6","key":"10.1016\/j.ejpb.2021.09.011_b0215","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1194\/jlr.R800009-JLR200","article-title":"Nuclear sphingolipids: metabolism and signaling","volume":"49","author":"Ledeen","year":"2008","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.ejpb.2021.09.011_b0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-physiol-020911-153321","article-title":"Nuclear Sphingolipid Metabolism","volume":"74","author":"Lucki","year":"2012","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejpb.2021.09.011_b0225","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/jps.23672","article-title":"Non-Viral Nanosystems for Gene and Small Interfering RNA Delivery to the Central Nervous System: Formulating the Solution","volume":"102","author":"O\u2019Mahony","year":"2013","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ejpb.2021.09.011_b0230","first-page":"465","article-title":"Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer","volume":"3","author":"Zhang","year":"2003","journal-title":"Mol. Vis."},{"issue":"3","key":"10.1016\/j.ejpb.2021.09.011_b0235","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/pharmaceutics12030198","article-title":"Niosome-Based Approach for In Situ Gene Delivery to Retina and Brain Cortex as Immune-Privileged Tissues","volume":"12","author":"Al Qtaish","year":"2020","journal-title":"Pharmaceutics."},{"issue":"10","key":"10.1016\/j.ejpb.2021.09.011_b0240","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1021\/acs.molpharmaceut.5b00422","article-title":"Protamine\/DNA\/Niosome Ternary Nonviral Vectors for Gene Delivery to the Retina: The Role of Protamine","volume":"12","author":"Puras","year":"2015","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2021.09.011_b0245","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.neuron.2008.10.013","article-title":"The mystery and magic of glia: a perspective on their roles in health and disease","volume":"60","author":"Barres","year":"2008","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.ejpb.2021.09.011_b0250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrn2533","article-title":"Pathological and protective roles of glia in chronic pain","volume":"10","author":"Milligan","year":"2009","journal-title":"Nat. Rev. Neurosci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121002551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121002551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:45:10Z","timestamp":1760546710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121002551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":50,"alternative-id":["S0939641121002551"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.09.011","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingolipid extracts enhance gene delivery of cationic lipid vesicles into retina and brain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}